Australia’s drug regulator issues mental health warning for weight-loss drugs including Ozempic | Health

[ad_1] The medicines regulator has added two new safety warnings about mental health and contraception for people taking high-profile diabetes and weight loss drugs. The Therapeutic Goods Administration (TGA) says that because suicidal behaviour and ideation have been reported with these relatively new GLP-1 receptor agonists, doctors should “monitor patients for the emergence or worsening…

Read More

I Come to Praise SSRIs not to Bury Them

[ad_1] This talk was given in Maastricht at the invitation of David Linden, Scientific Director of the Mental Health and Neuroscience Research Institute on November 27 and again to a group f Primary Care Doctors in Sweden at the invitation of André Marx on Nov 28.  There were some great questions afterwards.  This post gives…

Read More

How Parents Can Help Children With Severe Atopic Dermatitis (Eczema)

[ad_1] Mild eczema can be treated primarily with over-the-counter treatments that moisturize skin and reduce itching. Moderate to severe eczema requires more advanced therapies and lifestyle changes. [3] Topical Treatments Treatment in children is similar to what’s used for adults, says Mallick. That means starting with moisturizers that are unscented and dye-free to repair the impaired…

Read More

How to Handle Holiday Stress

[ad_1]   Although the holidays are a fun time of year they are also a very stress time of year? 45% of Americans say they would prefer skipping the entire season because of financial pressure. Most Americans feel that the stress really starts to build around December 13th, grows worse through the 18th and peaks…

Read More

Op-ed: Inside the First Food and Agriculture Policy Summit: The Debates That Happened and Those That Didn’t

[ad_1] Op-ed: Inside the First Food and Agriculture Policy Summit: The Debates That Happened and Those That Didn’t December 01, 2025 | Source: New York City Food Policy Center | by Jaden Schapiro WASHINGTON, D.C. (FPC) — On October 28th, 2025, Food Tank held its first-ever Food and Agriculture Policy Summit at the George Washington University…

Read More

Lupin’s biosimilar Armlupeg gains U.S.FDA approval

[ad_1] Lupin today announced that the United States Food and Drug Administration (U.S. FDA) has approved Armlupeg (pegfilgrastim-unne) 6 mg/0.6 mL injection for subcutaneous use in a single-dose prefilled syringe, as biosimilar to Neulasta (pegfilgrastim) 6 mg/0.6 mL injection. The product will be manufactured at Lupin’s Biotech facility in Pune, which was inspected by the…

Read More